Serial 99792452
Live / Allowed — Approved for publication (as of 08 Sept 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 28 Apr 2026 filing date already counts against anyone who files later.
Record
- Serial number
- 99792452
- Mark type
- Design / logo
- Filed
- 28 Apr 2026
- Attorney of record
- Karen K. Won
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical and biological preparations, namely, an orally administered protein kinase C (PKC) inhibitor for treating cancer, tumors, melanoma, and carcinoma; pharmaceutical and biological preparations for use in oncology for medical treatment purposes; pharmaceutical and biological preparations for preventing, diagnosing, treating and managing cancer, tumors, melanoma, and carcinoma; pharmaceutical and biological preparations for preventing, diagnosing, treating and managing metastatic uveal melanoma, primary uveal melanoma, and cutaneous melanoma; therapeutic agents for targeting genetically defined cancers or tumors having GNAQ or GNA11 gene mutations, and destruction of diseased cells, for medical treatment purposes.
Owner
- Ideaya Biosciences, Inc., South San Francisco, CA, US
Prosecution history
- 08 Sept 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 02 Sept 2026 — ASSIGNED TO EXAMINER
- 01 Sept 2026 — NOTICE OF DESIGN SEARCH CODE E-MAILED
- 01 Sept 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 28 Apr 2026 — APPLICATION FILING RECEIPT MAILED
- 28 Apr 2026 — NEW APPLICATION ENTERED